Model
Edge
Navidea Biopharmaceuticals, Inc.
NAVB
Filing Type
8-K
Filing Date
7/5/2023
Updated
7/6/23, 10:39 AM
Filing
8-K
Earnings Release
Exhibits
8-K
Material Contracts, Unregistered Sales of Equity Securities, Other Events
EX-10.1
EXHIBIT 10.1
EX-99.1
Material Contracts, Unregistered Sales of Equity Securities, Other Events